Caveolae in the uptake and targeting of infectious agents and secreted toxins
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 49 (3) , 301-315
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Association of Caveolin with Chlamydia trachomatis Inclusions at Early and Late Stages of InfectionExperimental Cell Research, 2001
- Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entryThe EMBO Journal, 1998
- Development of Guillain‐Barré Syndrome following Campylobacter InfectionThe Journal of Infectious Diseases, 1997
- Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains.Journal of Cell Biology, 1996
- The Three-dimensional Crystal Structure of Cholera ToxinJournal of Molecular Biology, 1995
- The Cellular Isoform of the Prion Protein, PRPC, Is Associated with Caveolae in Mouse Neuroblastoma (N2a) CellsBiochemical and Biophysical Research Communications, 1995
- Remodeling Schemes of Intracellular PathogensScience, 1994
- Entry of cholera toxin into polarized human intestinal epithelial cells. Identification of an early brefeldin A sensitive event required for A1-peptide generation.Journal of Clinical Investigation, 1993
- Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ERCell, 1989
- The class I major histocompatibility antigen gene activated in a line of SV40-transformed mouse cells is H–2Dd, not Qa/TlaNature, 1985